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The development and clinical application of 2-methoxyestradiol (2-ME) as a new type of antitumor drug 
are limited due to its poor solubility, rapid metabolism in vivo, and large oral dosage. 2-ME-loaded pH-
sensitive liposomes (2-ME-PSLs) was prepared containing the lipids, Lipoid E-80 (E-80), cholesteryl 
hemisuccinate (CHEMS), and cholesterol (CHOL) via thin-film ultrasonic dispersion. First, preparation 
conditions of 2-ME-PSLs were optimized by orthogonal test. Then 2-ME-PSL was characterized, and the 
release behavior and stability of 2-ME-PSL in vitro were evaluated. The optimal preparation conditions 
for 2-ME-PSLs were as follows: 2-ME : E-80+CHEMS 1:15; CHOL : E-80+CHEMS 1:5; ultrasonication 
time 20 minutes. The mean particle size, PDI, zeta potential, and entrapment efficiency (EE) of 2-ME-
PSLs were 116 ± 9 nm, 0.161 ± 0.025, −22.4 ± 1.7 mV, and 98.6 ± 0.5%, respectively. As viewed under a 
transmission electron microscope, 2-ME-PSLs were well dispersed and almost spherical. They exhibited 
significant pH-sensitive properties and were fairly stable when diluted with a physiological solution. In 
conclusion, 2-ME-PSLs were successfully prepared and possessed a favorable pH sensitivity and good 
dissolution stability with a normal solution.
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INTRODUCTION
2-Methoxyestradiol (2-ME) is the physiological 
metabolite of 17β-estradiol, catalyzed by catechol-O-
methyltransferase (COMT) in vivo (Dubey, 2017). It 
exhibits antitumor effects against a broad spectrum of 
tumors, especially breast cancer (Salama et al., 2011; Zhao 
et al., 2017), by anti-angiogenesis, inhibiting proliferation, 
and/or inducing apoptosis (Massaro et al., 2017; Zou et al., 
2018). As a new type of antitumor drug, 2-ME is effective 
by oral administration. The use of 2-ME to treat breast 
cancer is currently in phase II clinical research. However, 
due to its poor water solubility, rapid metabolism in vivo, 
and a large oral dosage (Guo et al., 2017; Said et al., 2017), 
the development and clinical application of its products 
are limited. Therefore, it is important to focus on the 
development of new delivery systems for 2-ME.
A liposome, as an artificially prepared spherical 
vesicle composed of a lamellar phase lipid bilayer, has 
great potential application in drug delivery, especially 
for entrapping hydrophobic drugs to increase drug 
solubility and targeting (Benson, 2017; Giacometti et 
al., 2017; Zabielska-Koczywas, Lechowski, 2017). 
However, liposomes easily leak drugs in physiological 
environments, which is not a conducive phenomenon 
because it could not leads to drug aggregation in tumor 
sites (Wang et al., 2017). In order to improve the liposome 
therapeutic efficacy, multifunction liposomes have been 
designed (Dai et al., 2014; Chen et al., 2017; Chi et al., 
2017; Dai et al., 2017). Considering that the pH value of 
the tumor tissue (about 5.0) is lower than that of the normal 
tissue, pH-sensitive liposomes have been developed as 
an efficient system for controlled drug release to improve 
drug efficacy after intravenous administration (Liang et 
al., 2017; Lee, Thompson, 2017).
In this study, we prepared 2-ME-loaded pH-sensitive 
liposomes (2-ME-PSLs), which were stable in the 
physiological environment, and fused intelligently into 
the acidic environment of tumor tissues. After optimizing 
preparation conditions and characterizing the 2-ME-PSLs, 
we investigated their stability and in vitro release behavior 
for pH sensitivity. The study lays down a foundation for iD
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the future development and application of 2-ME in the 
treatment of various cancers..
MATERIAL AND METHODS
Material
2-methoxyestradiol was purchased from Aikeda 
Chemical Reagent Co., Ltd. (Sichuan, China), Lipoid 
E-80 from Lipoid GmbH (Ludwigshafen, Germany), 
cholesteryl hemisuccinate (CHEMS) and cholesterol 
(CHOL) from Tokyo Chemical Industry Co., Ltd. (Tokyo, 
Japan) and high-performance liquid-chromatography 
(HPLC)-grade methanol from Tianjin Kermel Chemical 
Reagent Co., Ltd. (Tianjin, China). All other reagents were 
of analytical grade.
Preparation of 2-ME-PSLs
The 2-ME-PSLs wasWe prepared via thin-film 
ultrasonic dispersion method, using the lipids E-80, CHOL 
and CHEMS in the formulation. Briefly, 2-ME (10 mg) and 
lipids were dissolved in chloroform and then evaporated at 
40° C under reduced pressure until the organic solvent was 
removed to form a thin lipid film. The dried lipid film was 
hydrated with phosphate-buffered saline (PBS; 10 mL) and 
then sonicated it in a bath-type sonicator at 100 W.
Orthogonal experiment
In the study, the preparation conditions for 2-ME-
PSL was optimized PSLs by orthogonal test on the basis 
of the pre-experiment; the ratios of 2-ME: lipid (A), 
lipid: cholesterol (B), and ultrasonic time (C) as factors; 
and particle size as the evaluation index. The lipid was 
a mixture of E-80 and CHEMS (1:1). The independent 
factors and the levels were shown in Table I. In order to 
reduce systematic errors, the experiments were replicated 
for 3 times and completely randomized. The particle size 
was expressed as a mean intensity diameter.
Characterization of 2-ME-PSLs
Particle size and zeta potential
The particle size, size distribution and zeta potential 
of 2-ME-PSLs were measured by dynamic light scattering 
(DLS) analysis using a Malvern Zetasizer Nano ZS90 
(Malvern Instruments, Malvern, UK). Each test was 
performed in triplicate. Results were expressed as mean 
± standard deviation (SD).
Morphology investigation
The morphology of 2-ME-PSLs was observed using 
a JEM-2010 transmission electron microscope (TEM; 
JEOL Co., Ltd., Japan) with the negative-staining method. 
After diluted with an appropriate amount of distilled water, 
a drop of the sample was deposited on a dedicated copper 
grid and then stained with 1% (w/v) uranyl acetate. The 
grid was positioned at room temperature and allowed to 
dry before observation.
Entrapment efficiency
The encapsulation efficiency (EE) of 2-ME in PSLs 
was determined according to the literature (Xu et al., 
2017) with a little modification. Briefly, 2-ME-PSLs (400 
μL) was centrifuged in an ultrafiltration tube (50 kDa; 
Millipore, Massachusetts, US) at 3000 rpm for 30 minutes 
to separate the water phase. Non-entrapped 2-ME in the 
water phase was determined directly and total 2-ME in 
the PSLs was determined after lysing the liposomes with 
methanol (1:5; v/v). 2-ME in the various samples were 
detected by HPLC using an LC-20AT pump and SPD-20A 
UV/VIS detector (Shimadzu Corp., Kyoto, Japan) and a 
Diamonsil C18 analytical column (200 × 4.6 mm, 5 μm; 
Dikma Technologies, Inc., Foothill Ranch, California, 
US). The mobile phase was a mixture of acetonitrile and 
double-distilled water (50/50, v/v) at a flow rate of 1.0 
mL/min and the detection wavelength was 205 nm. The 
HPLC method was validated by the studies on precision, 
accuracy and standard curve (data not shown). The 
entrapment efficiency (EE) was calculated according to 
the equation (1):
 (1)
In vitro release study
The in vitro release of 2-ME in PSLs was investigated 
using dialysis in 2 different PBS media (0.3% Tween-80, 
pH 7.4 ± 0.1 and 0.3% Tween-80, pH 5.5 ± 0.1) at 37 °C 
(Seong, Yun, Park, 2017). Briefly, 2.0 mL of 2-ME-PSLs 
TABLE I - Factor and level
Level
Factor
2-ME: 
E80+CHEMS
CHOL: 
E80+CHEMS
Sonication time 
(min)
1 1:10 1:4 20
2 1:12 1:5 30
3 1:15 1:6 40
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was put into a dialysis bag (molecular-weight cutoff 
[MWCO] = 8,000-14,000 Da), which was soaked in 
double-distilled water for 24 hours before use. The end-
sealed dialysis bags were then immersed in 100 mL release 
media stirred at 100 rpm at 37 °C. At pre-determined time 
intervals (1, 2, 4, 6, 8, 12, 24 h), an aliquot of 0.5 mL 
release media was withdrawn and replaced by an equal 
volume of pre-warmed fresh media. Concentrations of 
drug in the samples were determined by the HPLC method 
described above.
Stability study
Generally, 2-ME-PSLs was given by intravenous 
injection after dilution with 5% glucose or 0.9% sodium 
chloride injection. Thereforefor, the stability of 2-ME-
PSLs after diluted with 5% glucose or 0.9% sodium 
chloride injection was evaluated. The physicochemical 
properties, including appearance, droplet size and drug 
content, were then investigated.
RESULTS AND DISCUSSION
Preparation and optimization of 2-ME-PSLs
The main results of the orthogonal test and range 
analysis are shown in Table II. The major–minor order 
that affected particle size was A > C > B, that is, the 
ratio of 2-ME : E-80+CHEMS > sonication time > 
CHOL: E-80+CHEMS. The optimal levels of 2-ME : 
E-80+CHEMS and sonication time were 1:15 and 40 
minutes, respectively. Particle size decreased as the ratio 
decreased and as the sonication time increased. The 
optimal level of CHOL : E-80+CHEMS was 1:5. E-80, 
CHEMS, and CHOL as the part of the double molecular 
film affected the formation of liposomes. The optimal 
conditions for preparing 2-ME-PSLs were as follows: 
2-ME, 10 mg; E-80+CHEMS (1:1), 150 mg; CHOL, 30 
mg; distilled water, 10 mL; sonication, 40 minutes.
In this experiment, the liposomes exhibited pH 
sensitivity when the acid-responsive CHEMS were 
anchored to the lipid bilayer. The amount of CHEMS (E-
80 : CHEMS = 1:1) without optimization was according 
to the literature (Lee, Thompson, 2017). In the orthogonal 
experimental design, we selected particle size rather than 
EE as the evaluation index, mainly because 2-ME is a 
hydrophobic drug: if the EE was too low, it resulted in 
drug precipitation, which was visible to the naked eye. 
Therefore, the particle size was suitable to be as the 
evaluation index.
Characterization of 2-ME-PSLs
Droplet size distribution and zeta potential are 
shown in Figure 1. DLS analysis showed the mean 
particle size, polydispersity index (PDI), and zeta 
potential of 2-ME-PSLs to be 116 ± 9 nm, 0.161 ± 0.025, 
and −22.4 ± 1.7 mV, respectively. Figure 2 shows that 
2-ME-PSLs were almost spherical in shape and well 
dispersed without any clustering or aggregation. The 
particle size was consistent with that determined by DLS 
analysis, and EE was as high as 98%.
In vitro release study
In the in vitro release study, 0.3% Tween-80 
contained in PBS was used to meet the sink condition 
because of 2-ME’s poor solubility. Results are shown 
in Figure 3. A low level of 2-ME was released from 
the powder in PBS without Tween-80 at both pH 7.4 
and 5.5 (<20% at 24 hours), further demonstrating the 
poor solubility of 2-ME. Under the sink condition, 
the level of 2-ME released from the crude powder 
increased significantly, but different pH conditions had 
no effect on this level. Less than 10% of 2-ME was 
released from PSLs in the pH 7.4 PBS medium within 
the initial 12 hours, but the level increased markedly 
after 12 until 24 hours. However, in the pH 5.5 PBS 
medium, more than 90% of 2-ME was released from 
the liposomes during the initial 6 hours, and 2-ME was 
almost completely released within 8 hours. These release 
profiles suggested that 2-ME-PSLs had good stability 
TABLE II - The results of orthogonal test
No. A B C d/nm
1 1 1 1 218
2 1 2 2 175
3 1 3 3 165
4 2 1 2 148
5 2 2 3 135
6 2 3 1 174
7 3 1 3 117
8 3 2 1 128
9 3 3 2 139
K1 186 161 173
K2 152 146 154
K3 128 159 139
R 58 15 34
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to the lipid bilayer, which was conducive to 2-ME-PSLs 
accumulating and exerting their effectiveness in tumor 
tissues (Monteiro et al., 2017).
Stability study
As shown in Table III, when the 2-ME-PSLs were 
diluted with 1-10 times volume of normal saline soluiton, 
the appearance, particle size, and drug content showed 
no obvious changes. However, when 2-ME-PSLs were 
diluted with 5%, the samples were turbid, with subsequent 
occurrence of precipitation. The results suggested that 
2-ME-PSLs were stable when diluted with normal saline 
solution rather than 5% glucose. This could be due to the 
different pH values of normal saline solution (6.5-7.5) and 
5% glucose (3.5-6.5).
To evaluate the effect of pH on the stability of 
2-ME-PSLs, we confirmed the change in liposome 
size after incubation with pH 7.4 PBS and pH 5.5 PBS. 
As shown in Figure 4, the size of liposomes gradually 
increased when incubated with pH 5.5 PBS, reaching 
about 1500 nm at 45 minutes. On the other hand, the 
FIGURE 1 - Particle size and zeta potential of 2-ME-PSL.
FIGURE 2 - TEM image of 2-ME-PSL.
in a neutral environment (pH 7.4) and were released 
quickly in acidic environments (pH 5.5), demonstrating 
an obvious pH sensitivity. That is to say, rapid release 
during the delivery process could be avoided, and the 
effect of plasma on drug leakage was negligible. The 
release behavior of 2-ME-PSLs in different media was 
mainly caused by anchoring acid-responsive CHEMS 
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size of liposomes incubated with pH 7.4 PBS showed 
no obvious change. Furthermore, we could not observe 
a normal spherical morphology under TEM for the 
2-ME-PSLs incubated with pH 5.5 PBS for 45 minutes. 
These results suggested that 2-ME-PSLs could lyse at 
pH 5.5 and then release 2-ME, thus meeting our primary 
goal that 2-ME-PSLs are stable in blood circulation and 
quickly release the drug after accumulating in tumor 
tissues. The structure of CHEMS, which possesses pH-
sensitive properties, was the main reason for the pH 
sensitivity in 2-ME-PSLs. Because the pKa of CHEMS 
was 5.8, when CHEMS participated in the formation of 
a liposome membrane, the zeta potential should have 
been negative in a neutral and/or alkaline environment, 
consistent with the zeta potential measured above. When 
CHEMS entered an acidic environment, it was protonated 
and the carboxyl group was oriented on the surface of the 
liposomes, resulting in liposome membrane instability 
and the decomposition of the lipid bilayer (Xiong et al., 
2011; Chen et al., 2012). Therefore, 2-ME-PSLs could 
exist stably in a neutral blood circulation environment. 
After the liposomes had entered the tumor tissues, their 
bilayer membrane became unstable and fusogenesis 
FIGURE 3 - In vitro release curves of 2-ME-PSL under different conditions (n=3).
FIGURE 4 - The particle size of 2-ME-PSL incubation with 
different PBS (n=3).
TABLE III - The results of stability experiments (n=3)
Dilution times Appearance Particle size/nm PDI Drug content (%)
1 ivory, opalescence 129 0.21 99.1
2 ivory, opalescence 119 0.17 98.2
5 ivory, opalescence 117 0.19 97.1
10 ivory, opalescence 122 0.19 98.4
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occurred, thereby promoting drug release and exerting 
a therapeutic effect. In conclusion, the stability study 
proved that pH-sensitive 2-ME-PSLs were stable when 
diluted with normal saline and were therefore suitable 
for clinical use.
CONCLUSION
In this study, 2-ME-PSL was successfully prepared 
with good stability diluted with normal saline and 
significant pH sensitivity. From preliminary study, we 
predicted that 2-ME-PSLs would be stable in blood 
circulation and would release the drug rapidly after reaching 
tumor sites, thus achieving the preferable antitumor effect. 
We intend to further study the pharmacokinetics and 
pharmacodynamics of 2-ME-PSLs in vivo.
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